Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine

The efficacy of hydroxychloroquine (HCQ) therapy, a previous candidate drug for coronavirus disease 2019 (COVID-19), was denied in the global guideline. The risk of severe cardiac events associated with HCQ was inconsistent in previous reports. In the present case series, we show the tolerability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Tomohiro, Okamoto, Masaki, Matsuo, Norikazu, Naitou-Nishida, Yoshiko, Nouno, Takashi, Kojima, Takashi, Nishii, Yuuya, Uchiyashiki, Yoshihiro, Takeoka, Hiroaki, Nagasaki, Yoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057902/
https://www.ncbi.nlm.nih.gov/pubmed/36984543
http://dx.doi.org/10.3390/medicina59030541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057902/
https://www.ncbi.nlm.nih.gov/pubmed/36984543
http://dx.doi.org/10.3390/medicina59030541

Ejemplares similares